U.S. Rna Polymerases Market Size & Outlook, 2023-2030
U.S. rna polymerases market, 2018-2030 (US$M)
Related Markets
U.S. rna polymerases market highlights
- The U.S. rna polymerases market generated a revenue of USD 109.7 million in 2023 and is expected to reach USD 234.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 11.5% from 2024 to 2030.
- In terms of segment, mrna production was the largest revenue generating application in 2023.
- MRNA Production is the most lucrative application segment registering the fastest growth during the forecast period.
Rna polymerases market data book summary
| Market revenue in 2023 | USD 109.7 million |
| Market revenue in 2030 | USD 234.5 million |
| Growth rate | 11.5% (CAGR from 2023 to 2030) |
| Largest segment | Mrna production |
| Fastest growing segment | MRNA Production |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | MRNA Production, Other Applications |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Agilent Technologies Inc, Promega, New England Biolabs, RayBiotech, Qiagen NV, Takara Bio Inc, Abnova, Worthington Enterprises Inc, MyBiosource, Sino Biological, Biovision, Calzyme, ArcticZymes Technologies, MBL International Corporation, BPS Bioscience Inc., Bio-Techne Corp, ABclonal |
Other key industry trends
- In terms of revenue, U.S. accounted for 34.8% of the global rna polymerases market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. rna polymerases market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 26.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
RNA Polymerases Market Scope
RNA Polymerases Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. rna polymerases market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rna polymerases market will help companies and investors design strategic landscapes.
Mrna production was the largest segment with a revenue share of 74.48% in 2023. Horizon Databook has segmented the U.S. rna polymerases market based on mrna production, other applications covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. RNA Polymerases Application Outlook (Revenue, USD Million, 2018-2030)
- Biopharmaceutical Processing
- Oligonucleotide synthesis
- mRNA Production
- Other Applications
Reasons to subscribe to U.S. rna polymerases market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. rna polymerases market databook
-
Our clientele includes a mix of rna polymerases market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. rna polymerases market, including forecasts for subscribers. This country databook contains high-level insights into U.S. rna polymerases market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. rna polymerases market size, by application, 2018-2030 (US$M)
U.S. RNA Polymerases Market Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
